2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow RDEA3170 10 mg: new trials by email Literature Review of RDEA3170 10 mg trials Research Report on RDEA3170 10 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RDEA3170 and Febuxostat Combination Study in Gout Subjects RDEA3170 15 mg, RDEA3170 10 mg, RDEA3170 2.5 - Gout | Phase 2 | Completed | Ardea Biosciences, Inc. | 64 | 2014-10-01 | 2017-07-27 |
| RDEA3170 Monotherapy in Subjects With Gout Placebo, RDEA3170 5 mg, RDEA3170 10 mg - Gout | Phase 2 | Completed | Ardea Biosciences, Inc. | 172 | 2013-08-01 | 2015-07-01 |
Gout (2)
United States (2)
J. Hall (1) · J. Hall, MD (1)